BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11742130)

  • 1. Identification of tissue transglutaminase-reactive lysine residues in glyceraldehyde-3-phosphate dehydrogenase.
    Orru S; Ruoppolo M; Francese S; Vitagliano L; Marino G; Esposito C
    Protein Sci; 2002 Jan; 11(1):137-46. PubMed ID: 11742130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeats.
    Ruoppolo M; Orrù S; Francese S; Caputo I; Esposito C
    Protein Sci; 2003 Jan; 12(1):170-9. PubMed ID: 12493840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysine-rich histone (H1) is a lysyl substrate of tissue transglutaminase: possible involvement of transglutaminase in the formation of nuclear aggregates in (CAG)(n)/Q(n) expansion diseases.
    Cooper AJ; Wang J; Pasternack R; Fuchsbauer HL; Sheu RK; Blass JP
    Dev Neurosci; 2000; 22(5-6):404-17. PubMed ID: 11111157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides.
    Fleckenstein B; Qiao SW; Larsen MR; Jung G; Roepstorff P; Sollid LM
    J Biol Chem; 2004 Apr; 279(17):17607-16. PubMed ID: 14747475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases.
    Gentile V; Sepe C; Calvani M; Melone MA; Cotrufo R; Cooper AJ; Blass JP; Peluso G
    Arch Biochem Biophys; 1998 Apr; 352(2):314-21. PubMed ID: 9587422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered, highly reactive substrates of microbial transglutaminase enable protein labeling within various secondary structure elements.
    Rachel NM; Quaglia D; Lévesque É; Charette AB; Pelletier JN
    Protein Sci; 2017 Nov; 26(11):2268-2279. PubMed ID: 28857311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor.
    Mandrusiak LM; Beitel LK; Wang X; Scanlon TC; Chevalier-Larsen E; Merry DE; Trifiro MA
    Hum Mol Genet; 2003 Jul; 12(13):1497-506. PubMed ID: 12812978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate preference of transglutaminase 2 revealed by logistic regression analysis and intrinsic disorder examination.
    Csosz E; Bagossi P; Nagy Z; Dosztanyi Z; Simon I; Fesus L
    J Mol Biol; 2008 Nov; 383(2):390-402. PubMed ID: 18761350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length.
    Cooper AJ; Sheu KR; Burke JR; Onodera O; Strittmatter WJ; Roses AD; Blass JP
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12604-9. PubMed ID: 9356496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pellicle precursor proteins: acidic proline-rich proteins, statherin, and histatins, and their crosslinking reaction by oral transglutaminase.
    Yao Y; Lamkin MS; Oppenheim FG
    J Dent Res; 1999 Nov; 78(11):1696-703. PubMed ID: 10576165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Location of the major epsilon-(gamma-glutamyl)lysyl cross-linking site in transglutaminase-modified human plasminogen.
    Bendixen E; Harpel PC; Sottrup-Jensen L
    J Biol Chem; 1995 Jul; 270(30):17929-33. PubMed ID: 7629099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 2-dependent deamidation of glyceraldehyde-3-phosphate dehydrogenase promotes trophoblastic cell fusion.
    Iwai K; Shibukawa Y; Yamazaki N; Wada Y
    J Biol Chem; 2014 Feb; 289(8):4989-99. PubMed ID: 24375405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase.
    Mishra S; Murphy LJ
    J Biol Chem; 2004 Jun; 279(23):23863-8. PubMed ID: 15069073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-glutathionylation of glyceraldehyde-3-phosphate dehydrogenase induces formation of C150-C154 intrasubunit disulfide bond in the active site of the enzyme.
    Barinova KV; Serebryakova MV; Muronetz VI; Schmalhausen EV
    Biochim Biophys Acta Gen Subj; 2017 Dec; 1861(12):3167-3177. PubMed ID: 28935607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dimer interface mutation in glyceraldehyde-3-phosphate dehydrogenase regulates its binding to AU-rich RNA.
    White MR; Khan MM; Deredge D; Ross CR; Quintyn R; Zucconi BE; Wysocki VH; Wintrode PL; Wilson GM; Garcin ED
    J Biol Chem; 2015 Jan; 290(3):1770-85. PubMed ID: 25451934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: identification of modification sites in glyceraldehyde-3-phosphate dehydrogenase.
    Ishii T; Tatsuda E; Kumazawa S; Nakayama T; Uchida K
    Biochemistry; 2003 Apr; 42(12):3474-80. PubMed ID: 12653551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of secreted glyceraldehyde-3-phosphate dehydrogenase in the infection mechanism of enterohemorrhagic and enteropathogenic Escherichia coli: interaction of the extracellular enzyme with human plasminogen and fibrinogen.
    Egea L; Aguilera L; Giménez R; Sorolla MA; Aguilar J; Badía J; Baldoma L
    Int J Biochem Cell Biol; 2007; 39(6):1190-203. PubMed ID: 17449317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic synthesis of vasoactive intestinal peptide analogs by transglutaminase.
    Esposito C; Cozzolino A; Mariniello L; Stiuso P; De Maria S; Metafora S; Ferranti P; Cartenì-Farina M
    J Pept Res; 1999 Jun; 53(6):626-32. PubMed ID: 10408336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tissue transglutaminase on the solubility of proteins containing expanded polyglutamine repeats.
    Lai TS; Tucker T; Burke JR; Strittmatter WJ; Greenberg CS
    J Neurochem; 2004 Mar; 88(5):1253-60. PubMed ID: 15009681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay.
    Doiphode PG; Malovichko MV; Mouapi KN; Maurer MC
    Anal Biochem; 2014 Jul; 457():74-84. PubMed ID: 24751466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.